Catalyst Wire Dossier Catalyst Wire Dossier

PV-001 9-valent HPV vaccine

· POSVAX
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PV-001 9-valent HPV vaccine, covering 2025-07-23 to 2025-07-23. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1 Study of PV-001 9-valent Human Papillomavirus(HPV) Vaccine [Phase 1]

See pricing